Bainbridge-Ropers syndrome (BRS) is a rare neurodevelopmental disorder caused by truncating mutations in the epigenetic regulator ASXL3. While traditionally considered a haploinsufficiency disorder, the precise molecular mechanisms driving BRS remain poorly understood. Here, we combine patient-derived cellular lines and novel mouse models to elucidate the molecular function of disease-associated ASXL3 variants.
Truncated ASXL3 Alters Chromatin Accessibility and Epigenetic Landscape in Bainbridge-Ropers Syndrome Suggesting a Gain-of-Function Etiology
calendar_today
August 5, 2026
person
Mor, N., Shomer, I., Raviv, S., Budick-Harmelin, N., Matzevitch, T., Azriel, S., Gleeson, J. G., Rais, Y., Haffner, R., Ben-Dor, S., Nayshool, O., Avkin-Nachum, S., Yahalom, A., Glick-Saar, E., Heimer, G., Rechavi, G., Dominissini, D.
domain
medrxiv